Hereditary non-polyposis colorectal cancer syndrome: Combined risk of gastrointestinal and gynaecological cancer

British Journal of Obstetrics and Gynaecology

Volumn 108, Issue 7, 2001, Pages 671-677

  Sharma, Anil ^a   James, Margaret ^b   Donaldson, Alan ^c   Fox, Robert ^b  

^a ROYAL GWENT HOSPITAL   (United Kingdom)

^b TAUNTON AND SOMERSET HOSPITAL   (United Kingdom)

^c BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RISK; CLINICAL FEATURE; CLINICAL GENETICS; COLORECTAL CANCER; DISEASE ASSOCIATION; DISEASE COURSE; ENDOMETRIUM CARCINOMA; FAMILY HISTORY; GASTROINTESTINAL CARCINOMA; GENE MUTATION; GENETIC COUNSELING; GYNECOLOGIC CANCER; HUMAN; MOLECULAR GENETICS; OVARY CARCINOMA; PRIORITY JOURNAL; REVIEW;

ADULT; AGED; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; ENDOMETRIAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; OVARIAN NEOPLASMS; PEDIGREE; RISK FACTORS;

EID: 0034887987     PISSN: 03065456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-5456(00)00174-1     Document Type: Review

References (56)

1. Hereditary nonpolyposis colorectal cancer syndrome
2. Hereditary nonpolyposis colorectal cancer (Lynch syndrome): An updated review
3. Extracolonic cancer in HNPCC
4. Molecular genetics and clinical-pathology features of hereditary nonpolypsis colorectal carcinoma (Lynch syndrome): Historical journey from pedigree anecdote to molecular genetic confirmation
5. International Collaborative Group for hereditary nonpolyposis colorectal cancer
6. Incidence of HNPCC and the feasibility of molecular screening
7. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC) syndrome proposed by the International Collaborative group on HNPCC
8. Biochemistry of and genetics of eukaryotic mismatch repair
9. Redundancy of Saccharomyces cerevisiae MSH3 and MSH6 in MSH2 mismatch repair
10. Appropriate partners make good matches
11. Genetic susceptibility to non-polyposis colorectal cancer
12. Mutator phenotypes in human colorectal carcinoma types
13. Genomic instability in repeated sequences is an early somatic event in colorectal tumorigenesis that persists after transformation
14. APC mutations in colorectal tumours with mismatch repair deficiency
15. Lessons from hereditary colorectal cancer
16. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability
17. Mutations of the transforming growth factor-beta type II receptor gene and genomic instability in hereditary nonpolyposis colorectal cancer
18. Microsatellite instability and mutations in the transforming growth factor b type II receptor gene in colorectal cancer
19. Microsatellite instability in the insulin-like-growth-factor-II receptor gene in gastrointestinal tumours
20. Frameshift mutator mutations
21. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype
22. Microsatellite instability in endometrial carcinomas: Frequent replication errors in tumours of early onset and/or of poorly differentiated type
23. Microsatellite instability in cervical and endometrial carcinomas
24. Cytogenetic abnormalities and microsatellite instability in endometrial adenocarcinoma
25. Absence of mutations in DNA mismatch repair genes in sporadic endometrial tumours with microsatellite instability
26. Microsatellite instability and expression of MLH1 and MSH2 in normal and malignant endometrial and ovarian epithelium in hereditary nonpolyposis colorectal cancer family members
27. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis
28. Colorectal and extracolonic cancer variations in MLH1/MSH2 hereditary nonpolyposis colorectal cancer kindred's and the general population
29. Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer
30. Genetic testing is important in families with a history suggestive of hereditary nonpolyposis colorectal cancer even if the Amsterdam criteria are not fulfilled
31. Missense mutations in hMLH1 associated with colorectal cancer
32. The accuracy of diagnoses as reported in families with cancer: A retrospective study
33. Microsatellite instability and mutation analysis of hMSH2 and hMLH1 in patients with sporadic, familial and hereditary colorectal cancer
34. Hereditary non polyposis colorectal cancer families not complying with the Amsterdam Criteria show extremely low frequency of mismatch-repair-gene mutations
35. Founding mutations and Alu-mediated recombination in hereditary colon cancer
36. DNA mismatch repair gene mutations in 55 kindred's with verified or putative hereditary nonpolyposis colorectal cancer
37. Mismatch repair genes in sporadic colorectal cancers with microsatellite instability
38. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients
39. MSH2 and MLH1 mutations in sporadic replication error-positive colorectal carcinoma as assessed by two-dimensional DNA electrophoresis
40. Evaluation of a counselling protocol for predictive genetic testing for hereditary non-polyposis colorectal cancer
41. Cancer risk in mutation carriers of DNA-mismatch-repair genes
42. Cancer risk associated with germline DNA mismatch repair gene mutations
43. Population-based detection of hereditary nonpolyposis colorectal cancer
44. Lessons from hereditary colorectal cancer
45. Recommendations for follow up care of individuals with an inherited predisposition to cancer: I. Hereditary nonpolyposis colon cancer
46. Controlled 15-year trial for colorectal cancer in families with hereditary nonpolyposis colorectal cancer
47. Self-promotion? Intimate connections between APC and prostaglandin H synthase-2
48. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis
49. Rectal cancer risk in hereditary nonpolyposis cancer after an abdominal colectomy
50. The risk of endometrial cancer in hereditary nonpolyposis colorectal cancer
51. Lifetime risk of different cancers in hereditary nonpolyposis colorectal cancer syndrome
52. Risk factors for endometrial cancer according to familial susceptibility
53. Endometrial cancer screening
54. Is total abdominal hysterectomy with bilateral salpingo-oophorectomy adequate for new FIGO stage I endometrial carcinoma?
55. Hereditary nonpolyposis colorectal cancer
56. Failure to diagnose hereditary colorectal cancer and its medico-legal implications